Use of substituted imidazo[1,2-A]-pyridine-3-yl-amide and imidazo[1,2-A]-pyridine-3-yl-amine compounds as medicaments for the treatment of neurodegenerative diseases

Details for Australian Patent Application No. 2002302503 (hide)

Owner GRUNENTHAL GMBH

Inventors Sundermann, Bernd; Hennies, Hagen-Heinrich; Maul, Corinna

Agent Spruson & Ferguson

Pub. Number AU-A-2002302503

PCT Number PCT/EP02/03796

PCT Pub. Number WO2002/080911

Priority 101 17 184.6 05.04.01 DE

Filing date 5 April 2002

Wipo publication date 21 October 2002

International Classifications

A61K 031/4188

A61P 025/28 Drugs for disorders of the nervous system

Event Publications

12 December 2002 Complete Application Filed

  Priority application(s): 101 17 184.6 05.04.01 DE

10 April 2003 Application Open to Public Inspection

  Published as AU-A-2002302503

20 October 2005 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(a). A direction to request examination has been given for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2002302504-Oryza sativa nuclear cap binding protein 80

2002302502-METHOD FOR IDENTIFICATION OR AUTHENTICATION